Logo for Seelos Therapeutics Inc

Seelos Therapeutics Investor Relations Material

Latest events

Logo for Seelos Therapeutics

Q2 2024

14 Aug, 2024
Logo for Seelos Therapeutics

Q1 2024

14 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Seelos Therapeutics Inc

Access all reports
Seelos Therapeutics, Inc. is a biotechnology company focused on developing treatments for central nervous system disorders and other rare diseases. The company’s research and development efforts target neurological, psychiatric, and neurodegenerative conditions. The company is headquartered in New York, New York, and its shares are listed on the OTCQB.